Gastroezofageal'naya reflyuksnaya bolezn' u beremennykh (lektsiya dlya praktikuyushchikh vrachey)
- Authors: Sharashkina N.V1, Runikhina N.K1
-
Affiliations:
- ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава РФ, Москва
- Issue: Vol 15, No 6 (2013)
- Pages: 24-26
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/93826
- ID: 93826
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
N. V Sharashkina
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава РФ, Москва
N. K Runikhina
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава РФ, Москва
References
- Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. М., 2008.
- Ивашкин В.Т., Шептулин А.А., Трухманов А.С. и др. Рекомендации по обследованию и лечению больных гастроэзофагеальной рефлюксной болезнью. М., 2002.
- Dent J, Jones R, Kahrilas P, Talley N.I. Management of gastrooesophageal reflux disease in general practice. BMJ 2001; 322: 344–7.
- Gill S.K, O'Brien L, Einarson T.R, Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta - analysis. Am J Gastroenterol 2009; 104 (6): 1541–5.
- Gill S.K, O’Brien L, Koren G. The safety of histamine 2 (H2) blockers in pregnancy: a meta - analysis. Dig Dis Sci 2009; 54 (9): 1835–8.
- Larson J.D, Patatanian E, Miner P.B et al. Double - blind, placebo - controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynec 1997; 90: 83–7.
- Lundell L. Advances in treatment strategies for gastroesophageal reflux disease. EAGE Postgraduate Course. Geneva, 2002; р. 13–22.
- Majithia R, Johnson D.A. Are proton pump inhibitors safe during pregnancy and lactation. Drugs 2012; 72 (2): 171–9.
- Malfertheiner S.F, Malfertheiner M.V, Kropf S et al. A prospective longitudinal cohort study: evolution of GERD symptoms during the course ofpregnancy. BMC Gastroenterol 2012; 12: 131.
- Naumann C.R, Zelig C, Napolitano P.G et al. Nausea, vomiting, and heartburn in pregnancy: a prospective look at risk, treatment, and outcome. J Matern Fetal Neonatal Med 2012; 25 (8): 1488–93.
- Ramu B, Mohan P, Rajasekaran M.S, Jayanthi V. Prevalence and risk factors for gastroesophageal reflux in pregnancy. Indian J Gastroenterol 2011; 30 (3): 144–7.
- Rey E, Rodríguez-Artalejo F, Herraiz M.A et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol 2007; 102 (11): 2395–400.
- Rey E, Rodríguez-Artalejo F, Herraiz M.A et al. Atypical symptoms of gastro - esophageal reflux during pregnancy. Rev Esp Enferm Dig 2011; 103 (3): 129–32.
- Rhim A.D, Hardy J.R, Haynes K et al. Maternal use of proton pump inhibitors during pregnancy is associated with an increased risk for cardiac birth defects: analysis of 208,951 pregnancies from the database (abstr). Gastroenterology 2010; 138: S-63.
- Richter J.E. Gastroesophageal reflux disease during pregnancy. Gastroent Clinics 2003; 32 (1): 235–61.
- Spechler S.J. Epidemiology of gastro - oesophageal history of gastrooesophageal reflux disease. Digestion 1992; 51 (Suppl. 1): 24–9.
- Stanghellini V. Management of gastroesophageal reflux disease. Drugs Today (Bare) 2003; 39 (Suppl. A): 15–20.
- Vakil N, van Zanten S.V, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence - based consensus. Am J Gastroenterol 2006; 101 (8): 1900–20.
Supplementary files
